Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Obes Surg ; 34(9): 3165-3172, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39046626

RESUMO

PURPOSE: With the escalating prevalence of obesity, healthcare providers are increasingly managing patients with a body mass index (BMI) exceeding 70. The aim of this study was to describe the perioperative experiences of this demographic group at two institutions. METHODS: An analysis encompassing 84 patients presenting with BMI ≥ 70 kg/m2 from two institutions was conducted. Data included patient demographics, 30-day postoperative outcomes, and weight-loss at different intervals (30 days, 6 months, 1 year). Additionally, rates of emergency department (ED) utilization, readmission, and reoperation in the first postoperative year were examined. RESULTS: Most patients were black (66.7%) and female (86.9%) with a mean age of 41.7 years. The majority underwent laparoscopic sleeve gastrectomy (SG, 88.1%). Patients exhibited a marked decrease in BMI (7.84% at 30 days, 20.13% at 6 months, and 26.83% at 1 year). Average length of stay was comparable across procedure (F(3,80) = 0.016, p = .997). While 30-day complications were minimal (0.7%), 14.4% of patients experienced ED visits within 30 days, escalating to 19.6% by six months and 25% at 1 year. Readmission and reoperation rates at 1 year were 6.45% and 4.83%, respectively. CONCLUSION: With global obesity rates rising, clinicians are being challenged to care for patients with BMI ≥ 70 kg/m2. Analysis of two institutions demonstrated low rates of 30-days complications but increased readmission rates and ED utilization in this patient population. Despite increased resource utilization, the study suggests that BMI ≥ 70 kg/m2 alone should not be a deterrent for surgery, emphasizing the need for nuanced care in this expanding demographic.


Assuntos
Cirurgia Bariátrica , Índice de Massa Corporal , Obesidade Mórbida , Readmissão do Paciente , Reoperação , Redução de Peso , Humanos , Feminino , Masculino , Adulto , Obesidade Mórbida/cirurgia , Resultado do Tratamento , Readmissão do Paciente/estatística & dados numéricos , Reoperação/estatística & dados numéricos , Cirurgia Bariátrica/estatística & dados numéricos , Cirurgia Bariátrica/métodos , Pessoa de Meia-Idade , Laparoscopia , Tempo de Internação/estatística & dados numéricos , Estudos Retrospectivos , Complicações Pós-Operatórias/epidemiologia , Gastrectomia/estatística & dados numéricos , Serviço Hospitalar de Emergência/estatística & dados numéricos
2.
Am J Cardiol ; 226: 128-133, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-39029720

RESUMO

The beneficial impacts of metabolic surgery (MS) on patients with heart failure (HF) are incompletely characterized. We aimed to describe the cardiac and metabolic effects of MS in patients with HF and hypothesized that patients with HF would experience both improved metabolic and HF profiles using glycemic control and diuretic dependency as surrogate markers. In this single-center, university-affiliated academic study in the United States, a review of 2,342 hospital records of patients who underwent MS (2017 to 2023) identified 63 patients with a medical history of HF. Preoperative characteristics, 30-day outcomes, and up to 2-year biometric and metabolic outcomes, medication usage, and emergency department utilization were collected. At 24 months, mean body mass index change was -16 kg/m2 (p <0.001) that corresponded to a mean percentage total body weight loss of 29% (p <0.001). Weight loss was accompanied by significant reductions in hemoglobin A1c (p <0.001) and a 65% decrease in diuretic use at 24 months after surgery (p <0.001). Similarly, emergency visits for cardiac conditions (p = 0.06) and intravenous diuresis (p = 0.07) trended favorably at 1 year after surgery compared with 1 year before surgery but were not statistically significant. In conclusion, in patients with HF who were carefully selected, MS appears to provide significant reduction in oral diuretic dependency, and metabolic improvements with trends toward lower rates of emergency department utilization.


Assuntos
Diuréticos , Insuficiência Cardíaca , Humanos , Feminino , Masculino , Diuréticos/uso terapêutico , Pessoa de Meia-Idade , Idoso , Estudos Retrospectivos , Redução de Peso , Hemoglobinas Glicadas/metabolismo , Resultado do Tratamento , Índice de Massa Corporal , Serviço Hospitalar de Emergência/estatística & dados numéricos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa